A Novel De Novo MTM1 Insertion Frameshift Variant Causes X-Linked Myotubular Myopathy in a Chinese Female.

Authors

Lijun Chen, Yingxiao Bao, Gonglu Liu

Published in

Molecular genetics & genomic medicine. Volume 14. Issue 10. Pages e70318.

Abstract

MTM1-related X-linked myotubular myopathy (XLMTM) typically affects males; however, symptomatic female carriers may occur.
We evaluated a 24-year-old woman with infantile hypotonia followed by slowly progressive, asymmetric proximal weakness with facial and ocular involvement. Clinical assessment, pulmonary function testing, electromyography, lower-limb muscle MRI, and muscle biopsy were performed. Next-generation sequencing and parental segregation analysis were conducted.
The patient developed progressive functional decline leading to wheelchair dependence. Investigations showed moderate-to-severe restrictive ventilatory impairment, a myopathic pattern on electromyography, and extensive fatty replacement on muscle MRI. Muscle biopsy demonstrated histopathological features consistent with centronuclear myopathy. Genetic testing identified a heterozygous MTM1 insertion, c.1266_1267insATGGTGATAAAAACCATTCA, predicted to cause a frameshift (p.Gly423MetfsTer48). The variant was absent in both parents, supporting a de novo event. To our knowledge, this MTM1 variant has not been previously reported.
This case expands the MTM1 variant spectrum and highlights that de novo MTM1 frameshift variants can underlie clinically significant XLMTM manifestations in females, underscoring the value of genetic testing in symptomatic women with centronuclear myopathy features.

PMID:
42827302
Bibliographic data and abstract were imported from PubMed on 03 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.